Top

Annals of Hematology

Published in:

01-08-2016 | Letter to the Editor

Seriously overestimated prognostic value of baseline and interim FDG-PET in diffuse large B cell lymphoma

Authors: Hugo J. A. Adams, Thomas C. Kwee

Published in: Annals of Hematology | Issue 8/2016

Excerpt

Dear Editor, …

Mikhaeel NG, Smith D, Dunn JT, Phillips M, Moller H, Fields PA, Wrench D, Barrington SF (2016) Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL. Eur J Nucl Med Mol Imaging. doi:10.1007/s00259-016-3315-7 PubMedPubMedCentral

Sun N, Zhao J, Qiao W, Wang T (2015) Predictive value of interim PET/CT in DLBCL treated with R-CHOP: meta-analysis. Biomed Res Int 2015:648572. doi:10.1155/2015/648572 PubMedPubMedCentral

Mamot C, Klingbiel D, Hitz F, Renner C, Pabst T, Driessen C, Mey U, Pless M, Bargetzi M, Krasniqi F, Gigli F, Hany T, Samarin A, Biaggi C, Rusterholz C, Dirnhofer S, Zucca E, Martinelli G (2015) Final results of a prospective evaluation of the predictive value of interim positron emission tomography in patients with diffuse large B-cell lymphoma treated with R-CHOP-14 (SAKK 38/07). J Clin Oncol 33(23):2523–2529. doi:10.1200/JCO.2014.58.9846 CrossRefPubMed

Adams HJ, de Klerk JM, Fijnheer R, Heggelman BG, Dubois SV, Nievelstein RA, Kwee TC (2015) Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma. Eur J Haematol 94(6):532–539. doi:10.1111/ejh.12467 CrossRefPubMed

Melchardt T, Troppan K, Weiss L, Hufnagl C, Neureiter D, Trankenschuh W, Schlick K, Huemer F, Deutsch A, Neumeister P, Greil R, Pichler M, Egle A (2015) Independent prognostic value of serum markers in diffuse large B-cell lymphoma in the era of the NCCN-IPI. J Natl Compr Cancer Netw 13(12):1501–1508

Dunleavy K, Pittaluga S, Maeda LS, Advani R, Chen CC, Hessler J, Steinberg SM, Grant C, Wright G, Varma G, Staudt LM, Jaffe ES, Wilson WH (2013) Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma. N Engl J Med 368(15):1408–1416. doi:10.1056/NEJMoa1214561 CrossRefPubMedPubMedCentral

Avivi I, Zilberlicht A, Dann EJ, Leiba R, Faibish T, Rowe JM, Bar-Shalom R (2013) Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era. Am J Hematol 88(5):400–405. doi:10.1002/ajh.23423 CrossRefPubMed

Nakayama H, Aisa Y, Ito C, Shimazaki K, Katsumata Y, Hayashi H, Nakazato T (2015) Importance of histologic verification of positive positron emission tomography/computed tomography findings in the follow-up of patients with malignant lymphoma. Clin Lymphoma Myeloma Leuk 15(12):753–760. doi:10.1016/j.clml.2015.07.636 CrossRefPubMed

Bhojwani D, McCarville MB, Choi JK, Sawyer J, Metzger ML, Inaba H, Davidoff AM, Gold R, Shulkin BL, Sandlund JT (2015) The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma. Br J Haematol 168(6):845–853. doi:10.1111/bjh.13219 CrossRefPubMed

Title: Seriously overestimated prognostic value of baseline and interim FDG-PET in diffuse large B cell lymphoma
Authors: Hugo J. A. Adams
Thomas C. Kwee
Publication date: 01-08-2016
Publisher: Springer Berlin Heidelberg
Published in: Annals of Hematology / Issue 8/2016
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-016-2710-2

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Seriously overestimated prognostic value of baseline and interim FDG-PET in diffuse large B cell lymphoma

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2016

Clinical and prognostic differences between ALK-negative anaplastic large cell lymphoma and peripheral T cell lymphoma, not otherwise specified: a single institution experience

Abdominal aortic thrombosis secondary to reactive thrombocytosis in a patient with iron deficiency anemia

A new extranodal scoring system based on the prognostically relevant extranodal sites in diffuse large B-cell lymphoma, not otherwise specified treated with chemoimmunotherapy

Hypoglycemia due to monoclonal anti-insulin antibody in a patient with multiple myeloma

Sequential development of chronic myelogenous leukemia and primary myelofibrosis in a patient with history of large B-cell lymphoma treated with radiotherapy and chemotherapy: two myeloid neoplasms with distinct genotypic profiles suggestive of biclonality in a single individual

Mutual relationship between serum ferroxidase activity and hemoglobin levels in elderly individuals

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page